Collagen autoimmunity to rheumatoid arthritis

Area of Science:

• Immunology
• Rheumatology
• Autoimmunity

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
• The role of anti-collagen antibodies in the pathogenesis of RA and other connective tissue diseases is not fully understood.

Purpose of the Study:

• To investigate the presence and significance of antibodies to native and denatured collagen types I, II, and III in patients with rheumatoid arthritis, gout, and scleroderma compared to healthy volunteers.
• To explore the correlation of anti-collagen antibodies with disease activity markers and HLA-DR4 antigen.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to measure antibodies against native and denatured human collagen types I, II, and III.
• Interleukin-1 (IL-1) production by synovial cells stimulated by collagens was assessed.
• Levels of rheumatoid factor, IgG, IgM, IgA, and HLA-DR4 antigen were measured.

Main Results:

• 19% of RA patients had antibodies to native collagen type II, which cross-reacted with collagen types I and III.
• Anti-collagen antibody activity was generally higher in synovial fluid than in serum.
• No significant correlation was found between collagen antibodies and rheumatoid factor, immunoglobulin levels, IL-1 production, or HLA-DR4 antigen in RA patients.

Conclusions:

• Collagen antibodies may play a role in joint pathology in a subset of rheumatoid arthritis patients.
• The findings suggest that collagen autoimmunity warrants further investigation in the context of RA.
• Anti-collagen antibodies do not appear to be a universal marker across all tested rheumatic conditions.